These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1358985)

  • 41. Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patients.
    Fenouillet E; Blanes N; Coutellier A; Gluckman JC
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1251-5. PubMed ID: 8142142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive markers of AIDS: a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphadenopathy.
    Böttiger B; Morfeldt-Månson L; Putkonen P; Nilsson B; Julander I; Biberfeld G
    Scand J Infect Dis; 1989; 21(5):507-14. PubMed ID: 2511625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection.
    McRae B; Lange JA; Ascher MS; de Wolf F; Sheppard HW; Goudsmit J; Allain JP
    AIDS Res Hum Retroviruses; 1991 Aug; 7(8):637-43. PubMed ID: 1931233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
    Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
    JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of infectious immune complexes in human immunodeficiency virus type 1 (HIV-1) infections: correlation with plasma viremia and CD4 cell counts.
    Fiscus SA; Wallmark EB; Folds JD; Fryer J; van der Horst CM
    J Infect Dis; 1991 Oct; 164(4):765-9. PubMed ID: 1680137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
    Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
    AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-HIV-1 antibody avidity is correlated with clinical status in infected children.
    Sciascia C; Palomba E; Gay V; Tovo PA
    Pediatr AIDS HIV Infect; 1996 Feb; 7(1):14-9. PubMed ID: 11361468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
    Royal W; Selnes OA; Concha M; Nance-Sproson TE; McArthur JC
    Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors and clinical presentation of acute primary HIV infection in India.
    Bollinger RC; Brookmeyer RS; Mehendale SM; Paranjape RS; Shepherd ME; Gadkari DA; Quinn TC
    JAMA; 1997 Dec; 278(23):2085-9. PubMed ID: 9403423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.
    Yerly S; Chamot E; Hirschel B; Perrin LH
    J Infect Dis; 1992 Aug; 166(2):269-76. PubMed ID: 1353103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitation of HIV-1 p24 antibody expressed as relative binding capacity p24 antigen (p24 RBC) in infants born to HIV-1 seropositive mothers: correlation of this serological marker with the HIV-1 maternal antibody course and p24 antigenemia detection.
    Portolani M; Meacci M; Pecorari M; Pietrosemoli P; Cermelli C; Cellini M; Tampieri A; Tartoni P; Stella F
    Viral Immunol; 1995; 8(2):93-9. PubMed ID: 8825294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum reactivity against an immunoregulatory sequence of HIV p24 in HIV-1-infected subjects.
    Cordiali Fei P; Solmone M; Prignano G; Pugliese O; Viora M; Luzzati A; Ameglio F
    Viral Immunol; 1994; 7(4):199-203. PubMed ID: 7576034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team.
    Lathey JL; Hughes MD; Fiscus SA; Pi T; Jackson JB; Rasheed S; Elbeik T; Reichman R; Japour A; D'Aquila RT; Scott W; Griffith BP; Hammer SM; Katzenstein DA
    J Infect Dis; 1998 Mar; 177(3):617-24. PubMed ID: 9498440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The clinical and immunological correlations between the p24 antigenemia levels and those of anti-p24 antibodies in HIV-seropositive children].
    Apetrei C; Buzdugan I; Mitroi I; Duca M
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(2):141-4. PubMed ID: 7549257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.
    Rusconi S; Riva A; Meroni L; Zehender G; Cocchi F; Scapellato L; Galli M
    Clin Exp Immunol; 1995 Oct; 102(1):26-30. PubMed ID: 7554395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the Determine™ fourth generation HIV rapid assay.
    Brauer M; De Villiers JC; Mayaphi SH
    J Virol Methods; 2013 Apr; 189(1):180-3. PubMed ID: 23391823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral aspects of anti-HIV immune responses in Zairians with AIDS: lower antigenemia does not correlate with immune complex levels.
    Kashala O; Kayembe K; Kanki P; Mukeba P; Diese M; Kalengayi M; Izzia KW; Essex M
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):251-8. PubMed ID: 8471316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia.
    Ravina A; Ficarra G; Chiodo M; Mazzetti M; Romagnani S
    J Oral Pathol Med; 1996 Mar; 25(3):108-11. PubMed ID: 9148036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.